The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Molecular cloning of a new transforming gene from a chemically transformed human cell line
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ
Benton, W. D., & Davis, R. W. (1977) · Science · doi:10.1126/science.322279 · Cited by 4,595
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Self-citationLambda replacement vectors carrying polylinker sequences
Frischauf, A.-M., Lehrach, H., Poustka, A., & Murray, N. (1983) · Journal of Molecular Biology · doi:10.1016/s0022-2836(83)80190-9 · Cited by 1,717
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Sukumar, S., Notario, V., Martin-Zanca, D., & Barbacid, M. (1983) · Nature · doi:10.1038/306658a0 · Cited by 706
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change
Taparowsky, E., Suard, Y., Fasano, O., Shimizu, K., Goldfarb, M., & Wigler, M. (1982) · Nature · doi:10.1038/300762a0 · Cited by 703
Ubiquitous, interspersed repeated sequences in mammalian genomes.
Jelinek, W. R., Toomey, T. P., Leinwand, L., Duncan, C. H., Biro, P. A., Choudary, P. V., Weissman, S. M., Rubin, C. M., Houck, C. M., Deininger, P. L., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1398 · Cited by 539
Cited by
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Self-citationIdentification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Self-citationComprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
Bargmann, C. I., Hung, M.-C., & Weinberg, R. A. (1986) · Cell · doi:10.1016/0092-8674(86)90779-8 · Cited by 1,006
Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G., & Comoglio, P. M. (1994) · Cell · doi:10.1016/0092-8674(94)90318-2 · Cited by 991
A genetic linkage map of the human genome
DONISKELLER, H. (1987) · Cell · doi:10.1016/0092-8674(87)90158-9 · Cited by 909
An overview of the c-MET signaling pathway
Organ, S. L., & Tsao, M.-S. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011422556 · Cited by 875
Activation of a novel human transforming gene, ret, by DNA rearrangement
Takahashi, M., Ritz, J., & Cooper, G. M. (1985) · Cell · doi:10.1016/0092-8674(85)90115-1 · Cited by 854
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martin-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 803
Clark, J., Rocques, P. J., Crew, A. J., Gill, S., Shipley, J., Chan, A. M.-L., Gusterson, B. A., & Cooper, C. S. (1994) · Nature Genetics · doi:10.1038/ng0894-502 · Cited by 774
Self-citationTHE MOLECULAR GENETICS OF CELLULAR ONCOGENES
Varmus, H. E. (1984) · Annual Review of Genetics · doi:10.1146/annurev.ge.18.120184.003005 · Cited by 756
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
O'Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitch, B., Prokop, C., Espinosa, R., Le Beau, M. M., Earp, H. S., & Liu, E. T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5016 · Cited by 742
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Sonnenberg, E., Meyer, D., Weidner, K. M., & Birchmeier, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.1.223 · Cited by 698
Identification of an Amplified, Highly Expressed Gene in a Human Glioma
Kinzler, K. W., Bigner, S. H., Bigner, D. D., Trent, J. M., Law, M. L., O'Brien, S. J., Wong, A. J., & Vogelstein, B. (1987) · Science · doi:10.1126/science.3563490 · Cited by 681
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.
Naldini, L., Weidner, K. M., Vigna, E., Gaudino, G., Bardelli, A., Ponzetto, C., Narsimhan, R. P., Hartmann, G., Zarnegar, R., & Michalopoulos, G. K. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07836.x · Cited by 660
Molecular and biochemical characterization of the human trk proto-oncogene.
Martin-Zanca, D., Oskam, R., Mitra, G., Copeland, T., & Barbacid, M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.1.24 · Cited by 602
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.
Zarnegar, R., & Michalopoulos, G. K. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.5.1177 · Cited by 569
Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F., & Comoglio, P. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05588.x · Cited by 565
Park, M., Dean, M., Kaul, K., Braun, M. J., Gonda, M. A., & Vande Woude, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6379 · Cited by 561
Self-citationMechanism of met oncogene activation
Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., & Vande Woude, G. F. (1986) · Cell · doi:10.1016/0092-8674(86)90564-7 · Cited by 560
Self-citationNovel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
Eder, J. P., Vande Woude, G. F., Boerner, S. A., & LoRusso, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1306 · Cited by 522
Self-citationc-Met: Structure, functions and potential for therapeutic inhibition
Ma, P. C., Maulik, G., Christensen, J., & Salgia, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023768811842 · Cited by 504
Nakajima, M., Sawada, H., Yamada, Y., Watanabe, A., Tatsumi, M., Yamashita, J., Matsuda, M., Sakaguchi, T., Hirao, T., & Nakano, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990501)85:9%3c1894::aid-cncr3%3e3.0.co;2-j · Cited by 494
Tyrosine kinase receptor indistinguishable from the c-met protein
Giordano, S., Ponzetto, C., Renzo, M. F. D., Cooper, C. S., & Comoglio, P. M. (1989) · Nature · doi:10.1038/339155a0 · Cited by 490
Self-citationSomatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
Kong-Beltran, M., Seshagiri, S., Zha, J., Zhu, W., Bhawe, K., Mendoza, N., Holcomb, T., Pujara, K., Stinson, J., Fu, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2749 · Cited by 490
Young, D., Waitches, G., Birchmeier, C., Fasano, O., & Wigler, M. (1986) · Cell · doi:10.1016/0092-8674(86)90785-3 · Cited by 481
A closely linked genetic marker for cystic fibrosis
White, R., Woodward, S., Leppert, M., O'Connell, P., Hoff, M., Herbst, J., Lalouel, J.-M., Dean, M., & Vande Woude, G. (1985) · Nature · doi:10.1038/318382a0 · Cited by 458
Self-citationActivating mutations for the Met tyrosine kinase receptor in human cancer
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B., & Vande Woude, G. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11445 · Cited by 442
Self-citationXiao, G.-H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011532898 · Cited by 417
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
Furge, K. A., Zhang, Y.-W., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203859 · Cited by 410
Self-citationBao, Z.-S., Chen, H.-M., Yang, M.-Y., Zhang, C.-B., Yu, K., Ye, W.-L., Hu, B.-Q., Yan, W., Zhang, W., Akers, J., et al. (2014) · Genome Research · doi:10.1101/gr.165126.113 · Cited by 409
Weidner, K. M., Sachs, M., & Birchmeier, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.1.145 · Cited by 408
Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., & Greene, M. I. (1985) · Cell · doi:10.1016/s0092-8674(85)80050-7 · Cited by 400
Maulik, G., Shrikhande, A., Kijima, T., Ma, P. C., Morrison, P. T., & Salgia, R. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00029-6 · Cited by 391
Oncogene Activation in Chemical Carcinogenesis
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60222-5 · Cited by 388
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
Li, C., Wu, J., Hynes, M., Dosch, J., Sarkar, B., Welling, T. H., Pasca di Magliano, M., & Simeone, D. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.009 · Cited by 386
c-MET as a potential therapeutic target and biomarker in cancer
Sierra, J. R., & Tsao, M.-S. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011422557 · Cited by 365
Rong, S., Segal, S., Anver, M., Resau, J. H., & Vande Woude, G. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4731 · Cited by 363
Self-citationMutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
Hu, H., Mu, Q., Bao, Z., Chen, Y., Liu, Y., Chen, J., Wang, K., Wang, Z., Nam, Y., Jiang, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.038 · Cited by 345
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
Roskoski, R. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105463 · Cited by 335
A novel germ line juxtamembrane Met mutation in human gastric cancer
Lee, J.-H., Han, S.-U., Cho, H., Jennings, B., Gerrard, B., Dean, M., Schmidt, L., Zbar, B., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203874 · Cited by 329
Self-citationFrequent amplification of the c-met gene in scirrhous type stomach cancer
Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., & Tahara, E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91548-5 · Cited by 328
Italiano, A., Mir, O., Mathoulin-Pelissier, S., Penel, N., Piperno-Neumann, S., Bompas, E., Chevreau, C., Duffaud, F., Entz-Werlé, N., Saada, E., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30825-3 · Cited by 326
Munshi, N., Jeay, S., Li, Y., Chen, C.-R., France, D. S., Ashwell, M. A., Hill, J., Moussa, M. M., Leggett, D. S., & Li, C. J. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1173 · Cited by 326
Molecular mechanism of stomach carcinogenesis
Tahara, E. (1993) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01212724 · Cited by 324
MET-dependent solid tumours — molecular diagnosis and targeted therapy
Guo, R., Luo, J., Chang, J., Rekhtman, N., Arcila, M., & Drilon, A. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0377-z · Cited by 323
The Met tyrosine kinase receptor in development and cancer
Gentile, A., Trusolino, L., & Comoglio, P. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9107-6 · Cited by 319
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., & Vande Woude, G. F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5152 · Cited by 312
Self-citationTargeting the HGF/c-MET Pathway in Hepatocellular Carcinoma
Goyal, L., Muzumdar, M. D., & Zhu, A. X. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2791 · Cited by 307
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1115 · Cited by 307
Self-citationHGF/SF‐met signaling in the control of branching morphogenesis and invasion
Zhang, Y., & Vande Woude, G. F. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10358 · Cited by 307
Self-citationStructure and function of hepatocyte growth factor
Nakamura, T. (1991) · Progress in Growth Factor Research · doi:10.1016/0955-2235(91)90014-u · Cited by 305
Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition
Roskoski, R. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.11.007 · Cited by 303
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
Abounader, R., & Laterra, J. (2005) · Neuro-Oncology · doi:10.1215/s1152851705000050 · Cited by 300
The human met oncogene is related to the tyrosine kinase oncogenes
Dean, M., Park, M., Le Beau, M. M., Robins, T. S., Diaz, M. O., Rowley, J. D., Blair, D. G., & Vande Woude, G. F. (1985) · Nature · doi:10.1038/318385a0 · Cited by 298
Self-citationReceptor Tyrosine Kinase-Targeted Cancer Therapy
Yamaoka, T., Kusumoto, S., Ando, K., Ohba, M., & Ohmori, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113491 · Cited by 297
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204976 · Cited by 288
Self-citationPrat, M., Narsimhan, R. P., Crepaldi, T., Rita Nicotra, M., Natali, P. G., & Comoglio, P. M. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490302 · Cited by 287
Lilienthal, I., & Herold, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186885 · Cited by 283
Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 281
Phage display screening of therapeutic peptide for cancer targeting and therapy
Saw, P. E., & Song, E.-W. (2019) · Protein & Cell · doi:10.1007/s13238-019-0639-7 · Cited by 279
Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product
Rubin, J. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(93)90015-5 · Cited by 277
Diagnosis and Molecular Classification of Lung Cancer
Rodriguez-Canales, J., Parra-Cuentas, E., & Wistuba, I. I. (2016) · Cancer Treatment and Research · doi:10.1007/978-3-319-40389-2_2 · Cited by 273
Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa.
Sakamoto, H., Mori, M., Taira, M., Yoshida, T., Matsukawa, S., Shimizu, K., Sekiguchi, M., Terada, M., & Sugimura, T. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.3997 · Cited by 268
Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer
Jiang, W. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00019-5 · Cited by 264
Lubensky, I. A., Schmidt, L., Zhuang, Z., Weirich, G., Pack, S., Zambrano, N., Walther, M. M., Choyke, P., Linehan, W. M., & Zbar, B. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65147-4 · Cited by 256
Hepatocyte Growth Factor Receptor Is a Coreceptor for Adeno-Associated Virus Type 2 Infection
Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., & Daida, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.609-614.2005 · Cited by 246
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
Fu, J., Su, X., Li, Z., Deng, L., Liu, X., Feng, X., & Peng, J. (2021) · Oncogene · doi:10.1038/s41388-021-01863-w · Cited by 235
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
Kong, D.-H., Kim, M., Jang, J., Na, H.-J., & Lee, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081786 · Cited by 161
MET: A Critical Player in Tumorigenesis and Therapeutic Target
Graveel, C. R., Tolbert, D., & Vande Woude, G. F. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009209 · Cited by 128
Judson, M. C., Bergman, M. Y., Campbell, D. B., Eagleson, K. L., & Levitt, P. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21969 · Cited by 80
MET Receptor Tyrosine Kinase as an Autism Genetic Risk Factor
Peng, Y., Huentelman, M., Smith, C., & Qiu, S. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00005-8 · Cited by 49
A new synaptic player leading to autism risk: Met receptor tyrosine kinase
Judson, M. C., Eagleson, K. L., & Levitt, P. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9081-8 · Cited by 43
Anti-EGFR Therapy in Metastatic Colorectal Cancer: Identifying, Tracking, and Overcoming Resistance
Leite, L. F., Noronha, M. M., de Menezes, J. S. A., da Conceição, L. D., Almeida, L. F. C., Cappellaro, A. P., Belotto, M., Biachi de Castria, T., Peixoto, R. D., & Megid, T. B. C. (2025) · Cancers · doi:10.3390/cancers17172804 · Cited by 32
“The PRESSING2 study employed an expanded molecular panel to identify uncommon genomic alterations in RAS wild-type mCRC patients undergoing anti-EGFR therapy [87].”
Estevam, G. O., Linossi, E. M., Macdonald, C. B., Espinoza, C. A., Michaud, J. M., Coyote-Maestas, W., Collisson, E. A., Jura, N., & Fraser, J. S. (2024) · eLife · doi:10.7554/elife.91619 · Cited by 22
“The TPR-MET fusion provides the advantage of studying MET’s kinase domain in a cytoplasmic, constitutively oligomerized, active, and HGF-free system (Figure 1A-B) (Cooper et al., 1984; Park et al., 1986; Peschard et al., 2001; Rodrigues and Park, 1993; Vigna et al., 1999; Mak et al., 2007; Pal et al., 2017; Lu et al.,…”
Estevam, G. O., Linossi, E., Rao, J., Macdonald, C. B., Ravikumar, A., Chrispens, K. M., Capra, J. A., Coyote-Maestas, W., Pimentel, H., Collisson, E. A., et al. (2025) · eLife · doi:10.7554/elife.101882 · Cited by 17
Estevam, G. O., Linossi, E., Rao, J., Macdonald, C. B., Ravikumar, A., Chrispens, K. M., Capra, J. A., Coyote-Maestas, W., Pimentel, H., Collisson, E. A., et al. (2025) · eLife · doi:10.7554/elife.101882.3 · Cited by 6
Metadata
- Authors
- Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., & Vande Woude, G. F.
- Venue
- Nature
- Published
- 1984-09-06
- Volume
- 311
- Issue
- 5981
- Pages
- 29-33
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2055787036
- Cited by
- 989
- References
- 36
- FWCI
- 43.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.